|
US2011165236A1
|
|
Controlled release hydrogel formulation
|
|
US2010239681A1
|
|
Controlled Release Particulates Containing Water-Insoluble Drug
|
|
WO2008076841A1
|
|
Pharmaceutical composition for reducing the risks associated with cardiovascular and cerebrovascular diseases
|
|
WO2008064259A2
|
|
Solid dispersion composition comprising fluvastatin
|
|
WO2008039615A2
|
|
Controlled release hydrogel formulation
|
|
WO2007117314A2
|
|
Bupropion controlled release formulations and methods of making
|
|
US2006099261A1
|
|
Methods and formulations for making controlled release oral dosage form
|
|
US2006099262A1
|
|
Methods and formulations for making controlled release oral dosage form
|
|
EP1811967A2
|
|
Methods and formulations for making pharmaceutical compositions containing bupropion
|
|
TW200621314A
|
|
Methods and formulations for making pharmaceutical compositions containing bupropion
|
|
US2004247679A1
|
|
Pharmaceutical composition and method for treating
|
